North America Maternal Mental Health Market To Reach $20.63 Billion By 2030

North America Maternal Mental Health Market Growth & Trends

The North America maternal mental health market size is expected to reach USD 20.63 billion by 2030, growing at a CAGR of 29.68% from 2023 to 2030, according to a new report by Grand View Research, Inc. The maternal mental health industry in the U.S. has been growing in recent years, with increased awareness, improved screening and assessment, and efforts to enhance access to care. However, disparities in access as well as gaps in mental well-being support for vulnerable populations still exist. The Canadian government has implemented regulations and provided funding to address maternal mental conditions.

These include initiatives such as maternity leave benefits under the Employment Insurance program, mental well-being strategies, funding for perinatal mental health services, collaborative care models, research and data collection, and support for community-based organizations. These efforts aim to improve access to mental well-being services and support for pregnant women and new mothers across Canada. Moreover, the Wisconsin Department of Health Services (DHS) announced awards totaling USD 16 million in October 2022 to enhance maternal and child health. The funds will be invested to close maternal and child health outcomes gaps through collaborations with the Medical College of Wisconsin’s Advancing a Healthier Wisconsin Endowment and the University of Wisconsin School of Medicine and Public Health.

In addition, this initiative offers funding to DHS Maternal and Child Health Program to manage a grant program. This program will provide funding for initiatives that promote maternal and child health equity to reduce maternal and infant mortality at the systemic and community levels and improve outcomes for families throughout Wisconsin. Each partner will receive USD 5.5 million to help them with their projects. With the help of increased funds, the government can determine the precise causes of each maternal mortality. The government will then be able to extend and implement evidence-based programs in hospitals and other birthing facilities to deal with the fundamental problems that result in poor maternal condition outcomes.

Although postnatal depression affects 15% of new mothers, it is frequently masked by stigma, societal expectations, and lack of medical knowledge. Despite the stigmatizing nature of mental illness, women have shown ingenuity and resilience by using acceptable cultural movements to reframe their experiences of PPD, challenging conventional views of motherhood, and successfully gaining recognition of their sufferings. The social stigma associated with PPD is a serious problem in the U.S. Many people think PPD is an unreal ailment or a sign of weakness. Therefore, some women might hesitate to seek treatment for PPD out of concern that they would be stigmatized or condemned.

 Request a free sample copy or view report summary: North America Maternal Mental Health Market Report

North America Maternal Mental Health Market Report Highlights

• The pregnancy and postpartum general anxiety segment accounted for the largest share in 2022. Increasing awareness and recognition of perinatal mental condition issues including anxiety disorders is the major factor driving the segment growth

• The PPD segment is expected to witness a lucrative CAGR through 2023 - 2030 owing to the favorable reimbursement scenario, increasing awareness for screening, and approval of novel therapies

• IPT dominated the market in 2022 as IPT is considered an effective therapy for treating a variety of mental conditions

• The U.S. led the regional market due to factors contributing such as robust government funding, increasing research, and the presence of prominent players

North America Maternal Mental Health Market Segmentation

Grand View Research has segmented the North America maternal mental health market based on disease indication, therapy, and region:

North America Maternal Mental Health Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Postpartum Depression

• Dysthymia

• Pregnancy and Postpartum General Anxiety

• Pregnancy and Postpartum OCD

• Birth-Related PTSD

• Others

North America Maternal Mental Health Therapy Outlook (Revenue, USD Million, 2018 - 2030)

• Antidepressants

  • Selective Serotonin Reuptake Inhibitors (SSRIs)

  • Tricyclic Antidepressants (TCAs)

  • Others

• Interpersonal Psychotherapy (IPT)          

• Cognitive Behavioral Therapy (CBT)         

• Others

North America Maternal Mental Health Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

List of Key Players in the North America Maternal Mental Health Market

• Therapy Mama

• Canopie

• Pfizer Inc

• Viatris Inc.

• GlaxoSmithKline Inc.

• Alembic Pharmaceuticals Limited

• Mallinckrodt Inc.

• Sage Therapeutics, Inc.

• Bausch Health Companies Inc.

• Magellan Health, Inc.